Dror Limon

1.0k total citations
45 papers, 395 citations indexed

About

Dror Limon is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Dror Limon has authored 45 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 18 papers in Genetics and 16 papers in Oncology. Recurrent topics in Dror Limon's work include Glioma Diagnosis and Treatment (17 papers), Brain Metastases and Treatment (12 papers) and Advanced Radiotherapy Techniques (6 papers). Dror Limon is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), Brain Metastases and Treatment (12 papers) and Advanced Radiotherapy Techniques (6 papers). Dror Limon collaborates with scholars based in Israel, United States and Belgium. Dror Limon's co-authors include Felix Bokstein, Deborah T. Blumenthal, Aron Popovtzer, Zvi Ram, Alexander Lossos, Yuval Nachalon, Rachel Grossman, Jacob Shvero, Gideon Bachar and Emanuela Cagnano and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer Research.

In The Last Decade

Dror Limon

40 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dror Limon Israel 11 166 162 147 53 50 45 395
Chan Woo Wee South Korea 13 152 0.9× 170 1.0× 89 0.6× 47 0.9× 80 1.6× 55 398
Isabelle Tennevet France 9 171 1.0× 145 0.9× 126 0.9× 96 1.8× 51 1.0× 19 380
Despina Misailidou Greece 8 183 1.1× 278 1.7× 65 0.4× 51 1.0× 44 0.9× 9 417
Katsuya Maebayashi Japan 12 257 1.5× 125 0.8× 144 1.0× 54 1.0× 104 2.1× 38 581
M Slavík Czechia 11 191 1.2× 125 0.8× 102 0.7× 41 0.8× 73 1.5× 50 439
Weiyan Shi China 11 178 1.1× 124 0.8× 109 0.7× 19 0.4× 37 0.7× 18 315
Whoon Jong Kil United States 10 134 0.8× 112 0.7× 137 0.9× 25 0.5× 29 0.6× 28 430
Russell Maxwell United States 11 108 0.7× 187 1.2× 259 1.8× 13 0.2× 42 0.8× 32 496
Benjamin Chua Australia 13 123 0.7× 145 0.9× 86 0.6× 85 1.6× 65 1.3× 29 476
Petr Burkoň Czechia 10 224 1.3× 178 1.1× 87 0.6× 16 0.3× 33 0.7× 35 348

Countries citing papers authored by Dror Limon

Since Specialization
Citations

This map shows the geographic impact of Dror Limon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Limon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Limon more than expected).

Fields of papers citing papers by Dror Limon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dror Limon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Limon. The network helps show where Dror Limon may publish in the future.

Co-authorship network of co-authors of Dror Limon

This figure shows the co-authorship network connecting the top 25 collaborators of Dror Limon. A scholar is included among the top collaborators of Dror Limon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dror Limon. Dror Limon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dudnik, Elizabeth, I. Lavi, Ofer Rotem, et al.. (2025). The impact of brain MRI screening on stage IV NSCLC patients: A real world look at guidelines based care. Journal of the Neurological Sciences. 470. 123398–123398.
2.
Bareket‐Samish, Avital, Daniel A. Goldstein, Eli Rosenbaum, et al.. (2025). Challenges in Interpreting Survival Metrics in Clinical Trials: The Utility of Restricted Mean Survival Analyses. International Journal of Radiation Oncology*Biology*Physics. 122(2). 224–233.
3.
Nobel, H., Jonathan Ofer, Dror Limon, et al.. (2025). Long-term impact of bevacizumab for the treatment of brain radiation necrosis. Journal of Neuro-Oncology. 173(2). 289–296.
4.
Moore, Assaf, et al.. (2024). The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy. Frontiers in Oncology. 14. 1386058–1386058. 1 indexed citations
5.
Tschernichovsky, Roi, Shlomit Yust‐Katz, Ofer Rotem, et al.. (2024). Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment. Journal of Neuro-Oncology. 166(3). 461–469. 1 indexed citations
6.
Laviv, Yosef, Andrew A. Kanner, Dror Limon, et al.. (2024). Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients. Journal of Neuro-Oncology. 171(1). 201–211. 2 indexed citations
7.
8.
Limon, Dror, Alexandra Amiel, Noa Gordon, et al.. (2024). A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor. Neuro-Oncology Advances. 6(1). vdae154–vdae154. 1 indexed citations
9.
10.
Moore, Assaf, et al.. (2023). Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy. Frontiers in Oncology. 13. 1236113–1236113. 1 indexed citations
11.
Bashat, Dafna Ben, et al.. (2022). Model-free dynamic contrast-enhanced MRI analysis: differentiation between active tumor and necrotic tissue in patients with glioblastoma. Magnetic Resonance Materials in Physics Biology and Medicine. 36(1). 33–42. 1 indexed citations
12.
Gomel, Nir, Eliya Levinger, Ron Ram, Dror Limon, & Zohar Habot‐Wilner. (2021). Acute Lymphoblastic Leukemia Relapse Limited to the Anterior Chamber of the Eye and Treated with Novel CAR T-Cell Therapy. Case Reports in Ophthalmology. 12(3). 994–1001. 4 indexed citations
13.
14.
Limon, Dror, Noa Gordon, Lior H. Katz, et al.. (2018). Brain metastasis in gastroesophageal adenocarcinoma and HER2 status. Journal of Neuro-Oncology. 138(2). 315–320. 10 indexed citations
15.
Vidal, Liat, et al.. (2017). Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer—Systematic Review and Meta-analysis. The Cancer Journal. 23(2). 79–83. 20 indexed citations
16.
Limon, Dror, Frances McSherry, James E. Herndon, et al.. (2017). Single fraction stereotactic radiosurgery for multiple brain metastases. Advances in Radiation Oncology. 2(4). 555–563. 44 indexed citations
17.
Yust‐Katz, Shlomit, et al.. (2017). Aberrant paramagnetic signals outside the tumor volume on routine surveillance MRI of brain tumor patients. Journal of Neuro-Oncology. 134(2). 371–376. 1 indexed citations
18.
Yust‐Katz, Shlomit, et al.. (2016). Progressive diffuse meningioangiomatosis: Response to bevacizumab treatment. Neurology. 86(17). 1643–1644. 7 indexed citations
19.
Blumenthal, Deborah T., Michal Yalon, Gilad W. Vainer, et al.. (2016). Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors. Journal of Neuro-Oncology. 129(3). 453–460. 76 indexed citations
20.
Blumenthal, Deborah T., Addie Dvir, Alexander Lossos, et al.. (2016). Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients. Journal of Neuro-Oncology. 130(1). 211–219. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chan Woo Wee Breakdown of academic impact, for papers by Isabelle Tennevet Breakdown of academic impact, for papers by Despina Misailidou Breakdown of academic impact, for papers by Katsuya Maebayashi Breakdown of academic impact, for papers by M Slavík Breakdown of academic impact, for papers by Weiyan Shi Breakdown of academic impact, for papers by Whoon Jong Kil Breakdown of academic impact, for papers by Russell Maxwell Breakdown of academic impact, for papers by Benjamin Chua Breakdown of academic impact, for papers by Petr Burkoň
Rankless by CCL
2026